Marshall Financial Group LLC Edwards Lifesciences Corp Transaction History

Marshall Financial Group LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 01, 2023	BUY	$68.3 - $87.44 $145,479 - $186,247	2,130 Added 25.95%	10,338 $771,000
Q3 2022 Oct 12, 2022	BUY	$82.37 - $107.29 $1,400 - $1,823	17 Added 0.21%	8,208 $678,000
Q2 2022 Jul 25, 2022	SELL	$86.5 - $128.27 $43,077 - $63,878	-498 Reduced 5.73%	8,191 $779,000
Q1 2022 May 10, 2022	SELL	$101.96 - $128.34 $10,297 - $12,962	-101 Reduced 1.15%	8,689 $1.02 Million
Q4 2021 Jan 27, 2022	BUY	$106.37 - $130.68 $24,465 - $30,056	230 Added 2.69%	8,790 $1.14 Million
Q3 2021 Oct 28, 2021	BUY	$102.91 - $122.75 $41,575 - $49,591	404 Added 4.95%	8,560 $969,000
Q2 2021 Jul 14, 2021	BUY	$83.84 - $104.76 $683,799 - $854,422	8,156 New	8,156 $845,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Marshall Financial Group LLC, based on Form 13F filings with the SEC.

Stay updated on Marshall Financial Group LLC with notifications on news.